Intensive diabetes management in adolescents with type 1 diabetes: The importance of intensive follow-up

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 1, 2000, Pages 79-84

  Lawson, Margaret L ^a,b   Frank, Marcia R ^a   Fry, Marilyn K ^a   Perlman, Kusiel ^a   Sochett, Etienne B ^a   Daneman, Denis ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Adolescents; Education; Intensive

Indexed keywords

HEMOGLOBIN A1C;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; DIABETES CONTROL; DISEASE DURATION; HEALTH PROMOTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING;

EID: 0033970723     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.1.79     Document Type: Article

References (15)

1. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. The DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.
3. Sadler M, Bubb J, White NH. Implementation of intensified insulin therapy in children with new-onset IDDM. Diabetes 1994; Suppl 43: 504A.
4. Burgart V, Zimmerman D, Schwenk WF. Successful implementation of a multiple daily injection (MDI) insulin program in newly-diagnosed children with type 1 diabetes. J Pediatr Endocrinol Metab 1996; 9 (Suppl 2): 209 (Abst #9).
5. Hoffman RP, Tsalikian E. Lack of improvement in glycemic control following switch to multiple daily injection therapy in pediatric IDDM. J Pediatr Endocrinol Metab 1996; 9 (Suppl 2): 215 (Abst #35).
6. Schwartz S, Mosiman JM, Howard CP. Intensive diabetes management in school-aged children. J Pediatr Endocrinol Metab 1996; 9 (Suppl 2): 225 (Abst #74).
7. Grey M, Boland EA, Davidson M, Yu C, Sullivan-Bolyai S, Tamborlane WV. Short-term effects of coping skills training as an adjunct to intensive therapy in adolescents. Diabetes Care 1998; 21: 902-908.
8. Boland EA, Li J, Grey M, Tamborlane WV. Continuous subcutaneous insulin infusion (CSII): A "new" way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping skills in adolescents with diabetes. Pediatr Res 1999; 45: 491A.
9. The DCCT Research Group. Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 1995; 18: 1468-1478.
10. Lawson ML, Sochett EB, Frank MR, Fry MK, Daneman D. Reversibility of early markers of diabetic nephropathy in children and adolescents with IDDM. Diabetes 1996; 45 (Suppl 2): 747A.
11. 1c. Clin Chem 1984; 30: 1746-1752.
12. Mortensen HB, Hougaard PH, for the Hvidøre Study Group of Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997; 20: 714-720.
13. Tercyak KP, Johnson SB, Kirkpatrick KA, Silverstein JH. Offering a randomized trial of intensive therapy for IDDM to adolescents: reasons for refusal, patient characteristics, and recruiter effects. Diabetes Care 1998; 21: 213-215.
14. Dorchy H, Roggemans M-P, Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997; 20: 2-6.
15. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougneres PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A. Factors associated with glycemic control: A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 1998; 21: 1146-1153.